- Home
- SAMG vs NKTR Comparison
SAMG vs NKTR Comparison
Compare SAMG & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAMG
- NKTR
- Stock Information
- Founded
- SAMG 2002
- NKTR 1990
- Country
- SAMG United States
- NKTR United States
- Employees
- SAMG N/A
- NKTR N/A
- Industry
- SAMG Investment Managers
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- SAMG Finance
- NKTR Health Care
- Exchange
- SAMG Nasdaq
- NKTR Nasdaq
- Market Cap
- SAMG 151.4M
- NKTR 125.5M
- IPO Year
- SAMG 2013
- NKTR 1994
- Fundamental
- Price
- SAMG $14.86
- NKTR $8.51
- Analyst Decision
- SAMG
- NKTR Strong Buy
- Analyst Count
- SAMG 0
- NKTR 6
- Target Price
- SAMG N/A
- NKTR $73.75
- AVG Volume (30 Days)
- SAMG 69.2K
- NKTR 348.5K
- Earning Date
- SAMG 07-31-2025
- NKTR 08-07-2025
- Dividend Yield
- SAMG 5.39%
- NKTR N/A
- EPS Growth
- SAMG N/A
- NKTR N/A
- EPS
- SAMG 0.94
- NKTR N/A
- Revenue
- SAMG $124,771,000.00
- NKTR $87,248,000.00
- Revenue This Year
- SAMG $3.93
- NKTR N/A
- Revenue Next Year
- SAMG $5.56
- NKTR N/A
- P/E Ratio
- SAMG $15.79
- NKTR N/A
- Revenue Growth
- SAMG 5.51
- NKTR N/A
- 52 Week Low
- SAMG $13.54
- NKTR $6.48
- 52 Week High
- SAMG $19.20
- NKTR $22.79
- Technical
- Relative Strength Index (RSI)
- SAMG 50.15
- NKTR 42.19
- Support Level
- SAMG $14.44
- NKTR $7.99
- Resistance Level
- SAMG $15.01
- NKTR $9.71
- Average True Range (ATR)
- SAMG 0.29
- NKTR 1.37
- MACD
- SAMG 0.02
- NKTR -0.20
- Stochastic Oscillator
- SAMG 56.32
- NKTR 11.66
About SAMG Silvercrest Asset Management Group Inc.
Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.